Patent: 6,864,264
✉ Email this page to a colleague
Summary for Patent: 6,864,264
Title: | 1-adamantyl chalcones for the treatment of proliferative disorders |
Abstract: | The present invention relates to the compounds of the general formula (I), a composition for and a method of treating breast cancer or other proliferative disorders in a subject using a compound of general formula [I], ##STR1## wherein the substituents are as defined in the specification. |
Inventor(s): | Anderson; Gloria L. (Atlanta, GA), Kaimari; Tawfeq Abdul-Raheem (Kennesaw, GA) |
Assignee: | |
Application Number: | 10/224,723 |
Patent Claims: | see list of patent claims |
Details for Patent 6,864,264
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2039-03-29 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |